Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB)
$0.9001
+0.3020 ( +44.02% ) 7.7M
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Market Data
Open
$0.9001
Previous close
$0.5979
Volume
7.7M
Market cap
$3.20M
Day range
$0.5610 - $0.9470
52 week range
$0.4780 - $21.5000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Nov 27, 2024 |
| 10-q | Quarterly Reports | 70 | Nov 13, 2024 |
| 8-k | 8K-related | 15 | Oct 31, 2024 |
| 8-k | 8K-related | 13 | Oct 24, 2024 |
| 8-k | 8K-related | 14 | Sep 03, 2024 |
| 8-k | 8K-related | 13 | Aug 28, 2024 |
| 8-k | 8K-related | 13 | Aug 20, 2024 |
| 10-q | Quarterly Reports | 66 | Aug 14, 2024 |
| 8-k | 8K-related | 45 | Aug 14, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |